| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B7-H1 Antigen | 33 | 2024 | 1022 | 9.870 |
Why?
|
| ErbB Receptors | 61 | 2023 | 2295 | 8.250 |
Why?
|
| Breast Neoplasms | 161 | 2024 | 15694 | 6.090 |
Why?
|
| Cell Nucleus | 37 | 2020 | 1620 | 5.330 |
Why?
|
| Adenovirus E1A Proteins | 27 | 2016 | 163 | 4.940 |
Why?
|
| I-kappa B Kinase | 20 | 2014 | 250 | 4.550 |
Why?
|
| Cell Line, Tumor | 208 | 2024 | 14551 | 4.530 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 14 | 2021 | 661 | 4.520 |
Why?
|
| Neoplasms | 76 | 2024 | 15193 | 4.440 |
Why?
|
| Signal Transduction | 116 | 2024 | 11965 | 4.090 |
Why?
|
| Receptor, ErbB-2 | 51 | 2019 | 2518 | 3.870 |
Why?
|
| Phosphorylation | 85 | 2022 | 4804 | 3.680 |
Why?
|
| Triple Negative Breast Neoplasms | 18 | 2024 | 1215 | 3.680 |
Why?
|
| Mice | 232 | 2024 | 34495 | 3.600 |
Why?
|
| Gene Expression Regulation, Neoplastic | 91 | 2023 | 8873 | 3.580 |
Why?
|
| Animals | 280 | 2024 | 59536 | 3.400 |
Why?
|
| Carcinoma, Hepatocellular | 24 | 2024 | 2027 | 3.330 |
Why?
|
| Tumor Escape | 12 | 2022 | 251 | 3.210 |
Why?
|
| Drug Resistance, Neoplasm | 43 | 2023 | 5178 | 3.150 |
Why?
|
| Programmed Cell Death 1 Receptor | 14 | 2023 | 1048 | 3.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 19 | 2021 | 245 | 2.840 |
Why?
|
| Pyroptosis | 5 | 2024 | 22 | 2.750 |
Why?
|
| Proto-Oncogene Proteins c-akt | 35 | 2020 | 2054 | 2.730 |
Why?
|
| Genetic Therapy | 32 | 2021 | 1616 | 2.700 |
Why?
|
| Mice, Inbred BALB C | 45 | 2021 | 2314 | 2.660 |
Why?
|
| Proto-Oncogene Proteins c-met | 6 | 2024 | 419 | 2.620 |
Why?
|
| Apoptosis | 63 | 2024 | 7591 | 2.570 |
Why?
|
| Humans | 463 | 2024 | 261506 | 2.520 |
Why?
|
| Mammary Neoplasms, Experimental | 16 | 2019 | 494 | 2.500 |
Why?
|
| Cell Proliferation | 71 | 2024 | 7226 | 2.470 |
Why?
|
| Membrane Proteins | 25 | 2024 | 2819 | 2.450 |
Why?
|
| Galectins | 5 | 2023 | 71 | 2.450 |
Why?
|
| Carcinogenesis | 19 | 2023 | 1026 | 2.360 |
Why?
|
| Apoptosis Regulatory Proteins | 16 | 2019 | 621 | 2.330 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 8 | 2024 | 479 | 2.300 |
Why?
|
| Liver Neoplasms | 24 | 2024 | 4557 | 2.300 |
Why?
|
| Epithelial-Mesenchymal Transition | 24 | 2021 | 973 | 2.260 |
Why?
|
| Adaptor Proteins, Signal Transducing | 17 | 2024 | 1439 | 2.250 |
Why?
|
| Active Transport, Cell Nucleus | 16 | 2019 | 323 | 2.250 |
Why?
|
| Antineoplastic Agents | 55 | 2023 | 14289 | 2.180 |
Why?
|
| NF-kappa B | 24 | 2018 | 1549 | 2.160 |
Why?
|
| DNA-Binding Proteins | 29 | 2022 | 4821 | 2.160 |
Why?
|
| Protein Processing, Post-Translational | 13 | 2023 | 803 | 2.150 |
Why?
|
| Neoplastic Stem Cells | 18 | 2021 | 1443 | 2.120 |
Why?
|
| Ribonuclease, Pancreatic | 3 | 2021 | 53 | 2.090 |
Why?
|
| Mice, Nude | 65 | 2021 | 4307 | 2.050 |
Why?
|
| Xenograft Model Antitumor Assays | 55 | 2022 | 3821 | 1.990 |
Why?
|
| Neoplasm Proteins | 30 | 2023 | 3230 | 1.950 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 13 | 2019 | 163 | 1.940 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 5 | 2020 | 170 | 1.920 |
Why?
|
| Transcription Factors | 42 | 2024 | 5270 | 1.920 |
Why?
|
| Proto-Oncogene Proteins | 23 | 2020 | 2488 | 1.910 |
Why?
|
| Ribonucleases | 4 | 2024 | 88 | 1.900 |
Why?
|
| Nuclear Proteins | 28 | 2024 | 3343 | 1.890 |
Why?
|
| Forkhead Transcription Factors | 13 | 2019 | 778 | 1.850 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 11 | 2023 | 1265 | 1.820 |
Why?
|
| Cell Transformation, Neoplastic | 32 | 2023 | 2359 | 1.810 |
Why?
|
| Up-Regulation | 32 | 2022 | 2450 | 1.760 |
Why?
|
| Neoplasm Metastasis | 32 | 2020 | 5112 | 1.740 |
Why?
|
| Immunotherapy | 17 | 2023 | 3341 | 1.730 |
Why?
|
| Protein Binding | 40 | 2022 | 3438 | 1.700 |
Why?
|
| Protein Transport | 18 | 2020 | 734 | 1.680 |
Why?
|
| Ovarian Neoplasms | 26 | 2022 | 4638 | 1.680 |
Why?
|
| Histones | 15 | 2020 | 1466 | 1.670 |
Why?
|
| Tumor Microenvironment | 23 | 2024 | 2864 | 1.620 |
Why?
|
| Promoter Regions, Genetic | 35 | 2021 | 3101 | 1.620 |
Why?
|
| Tumor Necrosis Factor-alpha | 14 | 2018 | 1538 | 1.610 |
Why?
|
| Tumor Suppressor Proteins | 17 | 2018 | 1823 | 1.600 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 3 | 2022 | 59 | 1.580 |
Why?
|
| RNA, Long Noncoding | 15 | 2024 | 598 | 1.580 |
Why?
|
| Glycogen Synthase Kinase 3 | 9 | 2009 | 161 | 1.560 |
Why?
|
| Cell Membrane | 6 | 2020 | 850 | 1.540 |
Why?
|
| Twist-Related Protein 1 | 8 | 2019 | 127 | 1.490 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 11 | 2020 | 460 | 1.490 |
Why?
|
| Tyrosine | 11 | 2022 | 498 | 1.470 |
Why?
|
| Female | 208 | 2024 | 141928 | 1.450 |
Why?
|
| Quinazolines | 13 | 2017 | 923 | 1.450 |
Why?
|
| Transcriptional Activation | 14 | 2018 | 1070 | 1.440 |
Why?
|
| T-Lymphocytes | 8 | 2023 | 3869 | 1.430 |
Why?
|
| Ubiquitination | 21 | 2021 | 575 | 1.420 |
Why?
|
| Plant Extracts | 2 | 2022 | 215 | 1.420 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 9 | 2014 | 507 | 1.410 |
Why?
|
| MicroRNAs | 19 | 2017 | 2947 | 1.410 |
Why?
|
| Transfection | 39 | 2017 | 2944 | 1.400 |
Why?
|
| HeLa Cells | 25 | 2019 | 1643 | 1.370 |
Why?
|
| Exosomes | 4 | 2021 | 253 | 1.350 |
Why?
|
| Biomarkers, Tumor | 30 | 2024 | 10331 | 1.340 |
Why?
|
| Antibodies | 5 | 2021 | 838 | 1.330 |
Why?
|
| Cell Movement | 34 | 2021 | 2466 | 1.330 |
Why?
|
| Lung Neoplasms | 33 | 2024 | 11538 | 1.310 |
Why?
|
| Tumor Cells, Cultured | 51 | 2023 | 5395 | 1.300 |
Why?
|
| Colonic Neoplasms | 10 | 2021 | 1390 | 1.290 |
Why?
|
| Microfluidic Analytical Techniques | 3 | 2016 | 44 | 1.290 |
Why?
|
| Trans-Activators | 11 | 2015 | 1555 | 1.270 |
Why?
|
| HEK293 Cells | 28 | 2021 | 1489 | 1.240 |
Why?
|
| Neoplasms, Experimental | 8 | 2021 | 750 | 1.240 |
Why?
|
| Cell Death | 8 | 2023 | 671 | 1.230 |
Why?
|
| Mitochondrial Proteins | 10 | 2019 | 369 | 1.220 |
Why?
|
| Pancreatic Neoplasms | 18 | 2024 | 5061 | 1.210 |
Why?
|
| Carrier Proteins | 17 | 2022 | 2022 | 1.190 |
Why?
|
| Polycomb Repressive Complex 2 | 12 | 2018 | 160 | 1.180 |
Why?
|
| Repressor Proteins | 15 | 2021 | 1664 | 1.140 |
Why?
|
| Antibodies, Monoclonal | 18 | 2022 | 4367 | 1.120 |
Why?
|
| TOR Serine-Threonine Kinases | 15 | 2020 | 1546 | 1.110 |
Why?
|
| Molecular Targeted Therapy | 15 | 2022 | 2330 | 1.100 |
Why?
|
| Protein Stability | 14 | 2020 | 370 | 1.100 |
Why?
|
| RNA, Small Interfering | 32 | 2018 | 2216 | 1.100 |
Why?
|
| Proliferating Cell Nuclear Antigen | 5 | 2021 | 195 | 1.090 |
Why?
|
| Transcription, Genetic | 18 | 2019 | 3154 | 1.090 |
Why?
|
| Protein Kinase Inhibitors | 22 | 2023 | 4757 | 1.090 |
Why?
|
| Glycosylation | 8 | 2021 | 213 | 1.080 |
Why?
|
| Adenocarcinoma | 17 | 2021 | 7789 | 1.070 |
Why?
|
| Proteomics | 5 | 2018 | 1380 | 1.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 6 | 2022 | 129 | 1.050 |
Why?
|
| Neovascularization, Pathologic | 11 | 2016 | 1547 | 1.050 |
Why?
|
| Protein-Tyrosine Kinases | 10 | 2020 | 1756 | 1.050 |
Why?
|
| Cell Cycle Proteins | 16 | 2024 | 2045 | 1.040 |
Why?
|
| Cell Survival | 31 | 2022 | 3045 | 1.040 |
Why?
|
| Epidermal Growth Factor | 11 | 2016 | 423 | 1.030 |
Why?
|
| Down-Regulation | 20 | 2021 | 2074 | 1.020 |
Why?
|
| Receptors, Eph Family | 2 | 2022 | 19 | 1.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 15 | 2024 | 1678 | 1.000 |
Why?
|
| Cell Line | 28 | 2021 | 5114 | 1.000 |
Why?
|
| Phosphoproteins | 9 | 2017 | 1152 | 0.980 |
Why?
|
| Proteolysis | 9 | 2021 | 370 | 0.980 |
Why?
|
| Neoplasm Transplantation | 19 | 2018 | 1519 | 0.980 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 9 | 2011 | 1493 | 0.970 |
Why?
|
| Proteins | 8 | 2016 | 1963 | 0.970 |
Why?
|
| Carcinoma, Pancreatic Ductal | 10 | 2024 | 1724 | 0.970 |
Why?
|
| Protein Kinases | 10 | 2020 | 874 | 0.950 |
Why?
|
| Immunologic Surveillance | 3 | 2018 | 60 | 0.950 |
Why?
|
| Golgi Apparatus | 4 | 2020 | 147 | 0.940 |
Why?
|
| Proanthocyanidins | 1 | 2023 | 8 | 0.940 |
Why?
|
| Paclitaxel | 10 | 2016 | 1996 | 0.930 |
Why?
|
| Nuclear Envelope | 2 | 2015 | 39 | 0.930 |
Why?
|
| Aurora Kinase A | 7 | 2019 | 202 | 0.920 |
Why?
|
| Protein-Arginine N-Methyltransferases | 6 | 2021 | 209 | 0.920 |
Why?
|
| DNA Replication | 4 | 2019 | 744 | 0.890 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 14 | 2024 | 5319 | 0.890 |
Why?
|
| Cevanes | 1 | 2022 | 1 | 0.880 |
Why?
|
| Multigene Family | 3 | 2018 | 425 | 0.880 |
Why?
|
| Coffea | 1 | 2022 | 1 | 0.880 |
Why?
|
| Hand Sanitizers | 1 | 2022 | 2 | 0.880 |
Why?
|
| Macrophages | 7 | 2023 | 1304 | 0.880 |
Why?
|
| Enzyme Inhibitors | 14 | 2020 | 1879 | 0.870 |
Why?
|
| Gene Expression Profiling | 20 | 2020 | 5159 | 0.860 |
Why?
|
| Ubiquitin-Protein Ligases | 10 | 2022 | 854 | 0.860 |
Why?
|
| Cell Division | 25 | 2024 | 2489 | 0.850 |
Why?
|
| AMP-Activated Protein Kinases | 7 | 2021 | 413 | 0.850 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2022 | 64 | 0.840 |
Why?
|
| Mice, SCID | 21 | 2021 | 1869 | 0.840 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2021 | 15 | 0.830 |
Why?
|
| Aminoquinolines | 1 | 2022 | 46 | 0.830 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 6 | 2010 | 528 | 0.830 |
Why?
|
| Genes, erbB-2 | 10 | 2009 | 229 | 0.830 |
Why?
|
| Casein Kinase II | 1 | 2022 | 69 | 0.830 |
Why?
|
| TNF Receptor-Associated Factor 6 | 2 | 2019 | 37 | 0.820 |
Why?
|
| Immunohistochemistry | 24 | 2022 | 7548 | 0.820 |
Why?
|
| STAT3 Transcription Factor | 11 | 2020 | 1121 | 0.820 |
Why?
|
| Metformin | 3 | 2018 | 378 | 0.820 |
Why?
|
| Enzyme Activation | 18 | 2017 | 1764 | 0.820 |
Why?
|
| Ephrin-A4 | 1 | 2021 | 7 | 0.810 |
Why?
|
| Mammary Glands, Human | 5 | 2019 | 184 | 0.790 |
Why?
|
| Glycolysis | 11 | 2022 | 519 | 0.790 |
Why?
|
| Virus Internalization | 4 | 2022 | 88 | 0.790 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 19 | 0.780 |
Why?
|
| Tumor Suppressor Protein p53 | 15 | 2023 | 3552 | 0.780 |
Why?
|
| Erlotinib Hydrochloride | 4 | 2019 | 388 | 0.780 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 6 | 2017 | 376 | 0.770 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 6 | 2016 | 40 | 0.770 |
Why?
|
| MCF-7 Cells | 12 | 2021 | 550 | 0.760 |
Why?
|
| Poly(ADP-ribose) Polymerases | 4 | 2022 | 324 | 0.760 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 5 | 2023 | 430 | 0.760 |
Why?
|
| Immunity, Innate | 3 | 2021 | 677 | 0.750 |
Why?
|
| Phagocytosis | 2 | 2018 | 260 | 0.740 |
Why?
|
| Antibody Affinity | 1 | 2020 | 61 | 0.730 |
Why?
|
| Protein Kinase C-alpha | 3 | 2016 | 66 | 0.730 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2015 | 591 | 0.730 |
Why?
|
| Nitrogen | 1 | 2020 | 162 | 0.730 |
Why?
|
| Antibodies, Neutralizing | 4 | 2023 | 541 | 0.730 |
Why?
|
| PTEN Phosphohydrolase | 11 | 2019 | 986 | 0.720 |
Why?
|
| Receptors, Cell Surface | 2 | 2019 | 862 | 0.720 |
Why?
|
| Heterografts | 13 | 2021 | 733 | 0.720 |
Why?
|
| Leukemia, T-Cell | 1 | 2020 | 87 | 0.720 |
Why?
|
| Models, Biological | 15 | 2021 | 3254 | 0.710 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 275 | 0.710 |
Why?
|
| src-Family Kinases | 4 | 2013 | 478 | 0.710 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 4 | 2021 | 992 | 0.710 |
Why?
|
| DNA | 9 | 2022 | 2693 | 0.710 |
Why?
|
| Ligands | 8 | 2023 | 995 | 0.700 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2011 | 299 | 0.700 |
Why?
|
| Protein Phosphatase 2 | 7 | 2019 | 88 | 0.700 |
Why?
|
| Zinc Finger Protein GLI1 | 3 | 2016 | 111 | 0.700 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2019 | 21 | 0.700 |
Why?
|
| Methylation | 12 | 2021 | 597 | 0.690 |
Why?
|
| Inflammation | 7 | 2021 | 2522 | 0.690 |
Why?
|
| Lysine | 5 | 2010 | 422 | 0.690 |
Why?
|
| Gene Knockdown Techniques | 14 | 2021 | 1077 | 0.680 |
Why?
|
| Lipoylation | 1 | 2018 | 8 | 0.680 |
Why?
|
| Neoplasm Invasiveness | 26 | 2018 | 3981 | 0.680 |
Why?
|
| Antiviral Agents | 3 | 2022 | 1230 | 0.680 |
Why?
|
| Acetyltransferases | 2 | 2010 | 143 | 0.680 |
Why?
|
| Cytosine Deaminase | 2 | 2011 | 39 | 0.680 |
Why?
|
| Peptide Hydrolases | 2 | 2021 | 256 | 0.680 |
Why?
|
| beta Catenin | 9 | 2019 | 688 | 0.680 |
Why?
|
| Endostatins | 2 | 2011 | 48 | 0.680 |
Why?
|
| Protein Kinase C-delta | 1 | 2018 | 42 | 0.670 |
Why?
|
| Cell Cycle | 18 | 2018 | 2084 | 0.670 |
Why?
|
| Acyltransferases | 1 | 2018 | 62 | 0.670 |
Why?
|
| Endoplasmic Reticulum | 4 | 2020 | 308 | 0.670 |
Why?
|
| Cell Differentiation | 11 | 2021 | 4078 | 0.660 |
Why?
|
| Janus Kinase 1 | 1 | 2019 | 121 | 0.660 |
Why?
|
| Hexosyltransferases | 1 | 2018 | 10 | 0.660 |
Why?
|
| Mice, Inbred NOD | 9 | 2021 | 905 | 0.660 |
Why?
|
| Peptidylprolyl Isomerase | 2 | 2009 | 73 | 0.660 |
Why?
|
| DNA Repair | 7 | 2022 | 1872 | 0.650 |
Why?
|
| RNA, Messenger | 22 | 2017 | 6150 | 0.650 |
Why?
|
| beta Karyopherins | 3 | 2010 | 36 | 0.650 |
Why?
|
| Gene Expression Regulation | 13 | 2018 | 4053 | 0.650 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2019 | 249 | 0.650 |
Why?
|
| Disease Progression | 20 | 2021 | 6682 | 0.650 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 217 | 0.650 |
Why?
|
| Antineoplastic Agents, Phytogenic | 8 | 2016 | 852 | 0.640 |
Why?
|
| Esophageal Neoplasms | 11 | 2015 | 3168 | 0.640 |
Why?
|
| Estrogen Receptor alpha | 3 | 2019 | 701 | 0.640 |
Why?
|
| CTLA-4 Antigen | 2 | 2021 | 657 | 0.640 |
Why?
|
| Serpins | 3 | 2015 | 77 | 0.630 |
Why?
|
| Argonaute Proteins | 2 | 2020 | 40 | 0.630 |
Why?
|
| Cell Hypoxia | 5 | 2016 | 328 | 0.630 |
Why?
|
| Interleukin-6 | 4 | 2019 | 1038 | 0.630 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 582 | 0.630 |
Why?
|
| Prostatic Neoplasms | 13 | 2016 | 5767 | 0.620 |
Why?
|
| Immune Evasion | 1 | 2018 | 73 | 0.620 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 75 | 0.620 |
Why?
|
| Mammary Glands, Animal | 2 | 2012 | 533 | 0.620 |
Why?
|
| Cytoplasm | 6 | 2016 | 652 | 0.610 |
Why?
|
| DNA Damage | 10 | 2022 | 1954 | 0.600 |
Why?
|
| Specimen Handling | 1 | 2019 | 299 | 0.600 |
Why?
|
| Radiation Tolerance | 6 | 2022 | 629 | 0.590 |
Why?
|
| Prognosis | 37 | 2020 | 21713 | 0.590 |
Why?
|
| Mesoderm | 7 | 2010 | 404 | 0.580 |
Why?
|
| Subcellular Fractions | 3 | 2015 | 201 | 0.580 |
Why?
|
| Karyopherins | 5 | 2016 | 136 | 0.580 |
Why?
|
| Spike Glycoprotein, Coronavirus | 4 | 2023 | 222 | 0.580 |
Why?
|
| CDC2 Protein Kinase | 3 | 2011 | 176 | 0.580 |
Why?
|
| Gene Expression | 19 | 2017 | 3570 | 0.580 |
Why?
|
| Sirtuins | 2 | 2014 | 44 | 0.580 |
Why?
|
| Emodin | 3 | 2005 | 14 | 0.570 |
Why?
|
| Forkhead Box Protein O3 | 8 | 2013 | 113 | 0.560 |
Why?
|
| Arginine | 4 | 2021 | 500 | 0.560 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2010 | 612 | 0.560 |
Why?
|
| Cetuximab | 4 | 2017 | 472 | 0.560 |
Why?
|
| Mutation | 31 | 2023 | 15179 | 0.560 |
Why?
|
| Genes, Tumor Suppressor | 11 | 2018 | 1064 | 0.560 |
Why?
|
| Endocytosis | 4 | 2020 | 225 | 0.560 |
Why?
|
| Transplantation, Heterologous | 13 | 2018 | 1082 | 0.560 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2013 | 703 | 0.560 |
Why?
|
| Nuclear Localization Signals | 4 | 2012 | 46 | 0.550 |
Why?
|
| Kruppel-Like Transcription Factors | 7 | 2016 | 270 | 0.540 |
Why?
|
| Inflammasomes | 3 | 2023 | 161 | 0.530 |
Why?
|
| Caspases | 5 | 2021 | 661 | 0.530 |
Why?
|
| Recombinational DNA Repair | 2 | 2022 | 79 | 0.530 |
Why?
|
| Jurkat Cells | 3 | 2021 | 311 | 0.530 |
Why?
|
| Immunity | 1 | 2017 | 342 | 0.530 |
Why?
|
| Lymphocyte Activation | 4 | 2023 | 1688 | 0.520 |
Why?
|
| Cytoskeletal Proteins | 4 | 2005 | 492 | 0.520 |
Why?
|
| Viral Proteins | 2 | 2022 | 435 | 0.520 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2022 | 203 | 0.520 |
Why?
|
| Protein Biosynthesis | 4 | 2021 | 889 | 0.520 |
Why?
|
| Hepatitis | 1 | 2015 | 93 | 0.520 |
Why?
|
| Cell Fractionation | 1 | 2015 | 68 | 0.510 |
Why?
|
| Gene Knockout Techniques | 2 | 2013 | 276 | 0.510 |
Why?
|
| RNA Interference | 14 | 2018 | 1408 | 0.510 |
Why?
|
| Proteasome Endopeptidase Complex | 8 | 2019 | 589 | 0.510 |
Why?
|
| Liposomes | 13 | 2006 | 684 | 0.510 |
Why?
|
| Hedgehog Proteins | 3 | 2015 | 424 | 0.510 |
Why?
|
| Carcinoma, Squamous Cell | 11 | 2024 | 5437 | 0.500 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2016 | 67 | 0.500 |
Why?
|
| Blotting, Western | 22 | 2015 | 3536 | 0.500 |
Why?
|
| Antineoplastic Agents, Immunological | 6 | 2022 | 1249 | 0.500 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2018 | 129 | 0.500 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2022 | 1533 | 0.500 |
Why?
|
| Brain Neoplasms | 8 | 2020 | 4849 | 0.500 |
Why?
|
| Sodium-Glucose Transporter 1 | 3 | 2021 | 15 | 0.500 |
Why?
|
| Benzimidazoles | 4 | 2016 | 428 | 0.490 |
Why?
|
| Hypoglycemic Agents | 2 | 2018 | 586 | 0.490 |
Why?
|
| Antibodies, Monoclonal, Humanized | 14 | 2020 | 3251 | 0.490 |
Why?
|
| NIH 3T3 Cells | 8 | 2017 | 260 | 0.490 |
Why?
|
| Colorectal Neoplasms | 8 | 2022 | 3578 | 0.490 |
Why?
|
| Multiprotein Complexes | 4 | 2017 | 395 | 0.480 |
Why?
|
| Mice, Knockout | 17 | 2021 | 5710 | 0.480 |
Why?
|
| Binding Sites | 9 | 2022 | 2171 | 0.480 |
Why?
|
| Epithelium | 4 | 2010 | 720 | 0.480 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 2011 | 196 | 0.470 |
Why?
|
| Amino Acid Sequence | 15 | 2021 | 4233 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 18 | 2021 | 6942 | 0.470 |
Why?
|
| Epithelial Cells | 10 | 2018 | 1818 | 0.470 |
Why?
|
| RNA | 1 | 2019 | 1013 | 0.470 |
Why?
|
| Pyridines | 5 | 2019 | 1244 | 0.470 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2013 | 30 | 0.470 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2013 | 4 | 0.460 |
Why?
|
| Snail Family Transcription Factors | 10 | 2019 | 120 | 0.460 |
Why?
|
| Genetic Vectors | 12 | 2011 | 1694 | 0.460 |
Why?
|
| Tannins | 2 | 2023 | 5 | 0.460 |
Why?
|
| Cells, Cultured | 14 | 2021 | 5637 | 0.460 |
Why?
|
| Gene Transfer Techniques | 7 | 2012 | 716 | 0.450 |
Why?
|
| Qa-SNARE Proteins | 1 | 2013 | 37 | 0.450 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 3 | 2015 | 131 | 0.450 |
Why?
|
| Inflammation Mediators | 3 | 2015 | 423 | 0.450 |
Why?
|
| RNA-Binding Proteins | 8 | 2023 | 984 | 0.450 |
Why?
|
| Protein Interaction Maps | 1 | 2014 | 149 | 0.450 |
Why?
|
| Receptor Cross-Talk | 1 | 2013 | 79 | 0.450 |
Why?
|
| Receptors, CXCR4 | 4 | 2010 | 269 | 0.440 |
Why?
|
| Carcinoma | 8 | 2020 | 2578 | 0.440 |
Why?
|
| DNA Methylation | 7 | 2020 | 2669 | 0.440 |
Why?
|
| Disease Models, Animal | 23 | 2022 | 7222 | 0.430 |
Why?
|
| Ubiquitin | 9 | 2017 | 344 | 0.430 |
Why?
|
| Nitric Oxide | 3 | 2017 | 644 | 0.430 |
Why?
|
| Science | 2 | 2019 | 35 | 0.430 |
Why?
|
| Biomarkers | 8 | 2022 | 5047 | 0.430 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2014 | 203 | 0.430 |
Why?
|
| Exoribonucleases | 1 | 2012 | 42 | 0.430 |
Why?
|
| DNA Topoisomerases, Type II | 2 | 2018 | 116 | 0.430 |
Why?
|
| BRCA2 Protein | 4 | 2017 | 358 | 0.420 |
Why?
|
| Receptor, ErbB-3 | 2 | 2017 | 122 | 0.420 |
Why?
|
| Melanoma, Experimental | 5 | 2021 | 368 | 0.420 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2012 | 76 | 0.420 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2011 | 40 | 0.420 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2013 | 347 | 0.420 |
Why?
|
| 14-3-3 Proteins | 4 | 2016 | 143 | 0.420 |
Why?
|
| RNA Stability | 1 | 2012 | 125 | 0.410 |
Why?
|
| Glycoproteins | 5 | 2022 | 747 | 0.410 |
Why?
|
| RGS Proteins | 2 | 2023 | 61 | 0.410 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 16 | 2021 | 3639 | 0.410 |
Why?
|
| Molecular Docking Simulation | 2 | 2022 | 144 | 0.410 |
Why?
|
| Acetylation | 6 | 2018 | 508 | 0.410 |
Why?
|
| Microtubules | 1 | 2013 | 270 | 0.410 |
Why?
|
| Genes, rRNA | 1 | 2011 | 22 | 0.400 |
Why?
|
| Phosphotyrosine | 2 | 2013 | 111 | 0.400 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2022 | 80 | 0.400 |
Why?
|
| Cytidine Deaminase | 1 | 2011 | 83 | 0.400 |
Why?
|
| Pentosyltransferases | 1 | 2011 | 25 | 0.400 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 14 | 2020 | 15862 | 0.400 |
Why?
|
| Gamma Rays | 1 | 2012 | 242 | 0.400 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2017 | 194 | 0.400 |
Why?
|
| CARD Signaling Adaptor Proteins | 3 | 2018 | 113 | 0.390 |
Why?
|
| Molecular Sequence Data | 16 | 2013 | 6089 | 0.390 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 6 | 2024 | 1331 | 0.390 |
Why?
|
| Hepatitis B virus | 2 | 2015 | 217 | 0.390 |
Why?
|
| Mice, Transgenic | 9 | 2021 | 4143 | 0.390 |
Why?
|
| Benzenesulfonates | 2 | 2011 | 195 | 0.390 |
Why?
|
| Neurons | 2 | 2013 | 2287 | 0.390 |
Why?
|
| Cyclins | 2 | 2003 | 456 | 0.390 |
Why?
|
| Serine | 7 | 2018 | 388 | 0.390 |
Why?
|
| Nuclear Pore | 1 | 2010 | 17 | 0.390 |
Why?
|
| Adenovirus E1 Proteins | 1 | 2010 | 4 | 0.390 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2012 | 221 | 0.390 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2011 | 80 | 0.380 |
Why?
|
| Stem Cells | 3 | 2019 | 1213 | 0.380 |
Why?
|
| Chromatin Immunoprecipitation | 8 | 2016 | 518 | 0.380 |
Why?
|
| Neurogenesis | 1 | 2013 | 238 | 0.380 |
Why?
|
| Breast | 3 | 2016 | 1344 | 0.380 |
Why?
|
| Career Mobility | 2 | 2005 | 95 | 0.380 |
Why?
|
| Gene Silencing | 9 | 2018 | 837 | 0.380 |
Why?
|
| Ribonuclease III | 3 | 2017 | 182 | 0.380 |
Why?
|
| Coat Protein Complex I | 1 | 2010 | 19 | 0.380 |
Why?
|
| Survival Analysis | 12 | 2021 | 9180 | 0.380 |
Why?
|
| MAP Kinase Signaling System | 5 | 2013 | 848 | 0.370 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2019 | 488 | 0.370 |
Why?
|
| THP-1 Cells | 2 | 2021 | 55 | 0.370 |
Why?
|
| Multienzyme Complexes | 5 | 2018 | 213 | 0.370 |
Why?
|
| Oncogenes | 5 | 2019 | 673 | 0.370 |
Why?
|
| alpha-Fetoproteins | 2 | 2015 | 237 | 0.370 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 218 | 0.370 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2022 | 316 | 0.370 |
Why?
|
| Drug Delivery Systems | 4 | 2011 | 669 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2022 | 810 | 0.370 |
Why?
|
| eIF-2 Kinase | 3 | 2019 | 164 | 0.370 |
Why?
|
| Spheroids, Cellular | 4 | 2023 | 222 | 0.370 |
Why?
|
| Base Sequence | 14 | 2013 | 4917 | 0.360 |
Why?
|
| Genes, p53 | 4 | 2013 | 1090 | 0.360 |
Why?
|
| RNA Helicases | 1 | 2010 | 101 | 0.360 |
Why?
|
| Receptors, CCR | 1 | 2009 | 4 | 0.350 |
Why?
|
| Trastuzumab | 12 | 2014 | 696 | 0.350 |
Why?
|
| Bile Acids and Salts | 2 | 2009 | 246 | 0.350 |
Why?
|
| Telomerase | 3 | 2012 | 525 | 0.350 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 162 | 0.350 |
Why?
|
| Wnt Proteins | 3 | 2009 | 397 | 0.340 |
Why?
|
| Autophagy | 5 | 2019 | 927 | 0.340 |
Why?
|
| Morpholines | 4 | 2019 | 289 | 0.340 |
Why?
|
| Sirolimus | 7 | 2015 | 814 | 0.340 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 6 | 2011 | 275 | 0.340 |
Why?
|
| Genes, Viral | 3 | 1998 | 202 | 0.340 |
Why?
|
| Amino Acid Motifs | 5 | 2015 | 392 | 0.340 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2009 | 55 | 0.340 |
Why?
|
| Male | 54 | 2022 | 123000 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-abl | 3 | 2016 | 79 | 0.340 |
Why?
|
| Melanoma | 7 | 2023 | 5317 | 0.340 |
Why?
|
| Mouth Neoplasms | 3 | 2024 | 713 | 0.330 |
Why?
|
| Energy Metabolism | 4 | 2021 | 992 | 0.330 |
Why?
|
| Calcium Signaling | 1 | 2011 | 284 | 0.330 |
Why?
|
| Cadherins | 5 | 2014 | 660 | 0.330 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2008 | 534 | 0.330 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 264 | 0.330 |
Why?
|
| Transcription Activator-Like Effector Nucleases | 2 | 2018 | 6 | 0.330 |
Why?
|
| Cyclin D1 | 8 | 2010 | 576 | 0.330 |
Why?
|
| E1A-Associated p300 Protein | 4 | 2017 | 92 | 0.330 |
Why?
|
| Li-Fraumeni Syndrome | 2 | 2023 | 158 | 0.320 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2011 | 1555 | 0.320 |
Why?
|
| Adenoviruses, Human | 2 | 2011 | 181 | 0.320 |
Why?
|
| Pandemics | 3 | 2022 | 1559 | 0.320 |
Why?
|
| Epigenesis, Genetic | 8 | 2024 | 1399 | 0.320 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 459 | 0.320 |
Why?
|
| Antibiotics, Antineoplastic | 5 | 2023 | 726 | 0.320 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 3 | 2016 | 60 | 0.320 |
Why?
|
| BRCA1 Protein | 3 | 2022 | 493 | 0.310 |
Why?
|
| Transforming Growth Factor beta | 4 | 2021 | 1130 | 0.310 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2021 | 1016 | 0.310 |
Why?
|
| Human Embryonic Stem Cells | 2 | 2018 | 33 | 0.310 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2012 | 611 | 0.310 |
Why?
|
| Ceruloplasmin | 2 | 2005 | 35 | 0.310 |
Why?
|
| Endopeptidases | 3 | 2020 | 220 | 0.310 |
Why?
|
| 3T3 Cells | 6 | 2012 | 355 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2012 | 639 | 0.300 |
Why?
|
| Homeodomain Proteins | 7 | 2016 | 1143 | 0.300 |
Why?
|
| Androgen-Binding Protein | 2 | 2005 | 39 | 0.300 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2012 | 334 | 0.300 |
Why?
|
| Anilides | 3 | 2019 | 268 | 0.300 |
Why?
|
| Smad4 Protein | 2 | 2021 | 196 | 0.290 |
Why?
|
| Doxorubicin | 5 | 2023 | 3005 | 0.290 |
Why?
|
| Antigens, Neoplasm | 5 | 2022 | 1506 | 0.290 |
Why?
|
| Histone Deacetylases | 4 | 2016 | 365 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 4 | 2020 | 1491 | 0.290 |
Why?
|
| Receptor, TIE-2 | 2 | 2017 | 82 | 0.290 |
Why?
|
| Databases, Genetic | 4 | 2024 | 745 | 0.280 |
Why?
|
| Biphenyl Compounds | 3 | 2021 | 194 | 0.280 |
Why?
|
| Pyridones | 2 | 2019 | 348 | 0.280 |
Why?
|
| Obesity | 3 | 2023 | 2884 | 0.280 |
Why?
|
| Transgenes | 5 | 2014 | 557 | 0.280 |
Why?
|
| ADAM Proteins | 3 | 2024 | 134 | 0.280 |
Why?
|
| Vascular Endothelial Growth Factor C | 3 | 2014 | 30 | 0.280 |
Why?
|
| Cell Growth Processes | 6 | 2011 | 342 | 0.280 |
Why?
|
| Hypoxia | 3 | 2020 | 443 | 0.270 |
Why?
|
| SEC Translocation Channels | 2 | 2019 | 9 | 0.270 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2005 | 27 | 0.270 |
Why?
|
| Salmonella typhimurium | 1 | 2006 | 70 | 0.270 |
Why?
|
| Immunoprecipitation | 8 | 2014 | 591 | 0.270 |
Why?
|
| Receptor, Cholecystokinin A | 1 | 2005 | 8 | 0.270 |
Why?
|
| Endothelial Cells | 4 | 2023 | 1048 | 0.270 |
Why?
|
| Response Elements | 1 | 2006 | 193 | 0.270 |
Why?
|
| Benzamides | 3 | 2020 | 1832 | 0.270 |
Why?
|
| Cell Adhesion | 6 | 2013 | 1008 | 0.270 |
Why?
|
| Gene Editing | 2 | 2018 | 216 | 0.270 |
Why?
|
| Pyruvate Kinase | 3 | 2022 | 36 | 0.270 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2021 | 675 | 0.270 |
Why?
|
| Cullin Proteins | 2 | 2019 | 41 | 0.260 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 650 | 0.260 |
Why?
|
| Unfolded Protein Response | 2 | 2019 | 115 | 0.260 |
Why?
|
| Sphingosine | 2 | 2022 | 55 | 0.260 |
Why?
|
| E2F1 Transcription Factor | 2 | 2006 | 206 | 0.260 |
Why?
|
| Cytokines | 6 | 2019 | 2809 | 0.260 |
Why?
|
| Quinolines | 3 | 2019 | 383 | 0.260 |
Why?
|
| Adenoviridae | 6 | 2016 | 1459 | 0.260 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2024 | 1586 | 0.260 |
Why?
|
| Barrett Esophagus | 2 | 2008 | 569 | 0.260 |
Why?
|
| Cricetinae | 4 | 2007 | 706 | 0.260 |
Why?
|
| Vaccines, DNA | 1 | 2006 | 105 | 0.260 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2017 | 255 | 0.260 |
Why?
|
| Genetics | 1 | 2005 | 27 | 0.260 |
Why?
|
| Immunoblotting | 7 | 2021 | 886 | 0.260 |
Why?
|
| Mitosis | 2 | 2022 | 615 | 0.260 |
Why?
|
| Isoenzymes | 3 | 2016 | 614 | 0.260 |
Why?
|
| Expressed Sequence Tags | 1 | 2004 | 101 | 0.250 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2021 | 6207 | 0.250 |
Why?
|
| AC133 Antigen | 3 | 2021 | 110 | 0.250 |
Why?
|
| Protein Structure, Tertiary | 9 | 2014 | 1487 | 0.250 |
Why?
|
| Ribosomal Proteins | 2 | 2022 | 118 | 0.250 |
Why?
|
| Janus Kinase 2 | 4 | 2017 | 679 | 0.250 |
Why?
|
| Zebrafish Proteins | 2 | 2017 | 163 | 0.250 |
Why?
|
| Oxygen | 1 | 2009 | 754 | 0.250 |
Why?
|
| Genes, BRCA2 | 2 | 2004 | 309 | 0.250 |
Why?
|
| Bone Neoplasms | 6 | 2022 | 2576 | 0.250 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 264 | 0.250 |
Why?
|
| Dihematoporphyrin Ether | 2 | 2015 | 15 | 0.250 |
Why?
|
| S-Phase Kinase-Associated Proteins | 3 | 2013 | 51 | 0.250 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2005 | 85 | 0.240 |
Why?
|
| Calcium | 1 | 2011 | 1537 | 0.240 |
Why?
|
| Stroke | 1 | 2013 | 1144 | 0.240 |
Why?
|
| Angiogenesis Inhibitors | 5 | 2022 | 1248 | 0.240 |
Why?
|
| Antioxidants | 2 | 2023 | 507 | 0.240 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 314 | 0.240 |
Why?
|
| Genes, Reporter | 7 | 2021 | 798 | 0.240 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2005 | 112 | 0.240 |
Why?
|
| Claudins | 1 | 2024 | 47 | 0.240 |
Why?
|
| Ultraviolet Rays | 2 | 2007 | 575 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2004 | 64 | 0.240 |
Why?
|
| Pyrones | 3 | 2021 | 10 | 0.240 |
Why?
|
| Photosensitizing Agents | 2 | 2015 | 71 | 0.240 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2004 | 98 | 0.240 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 215 | 0.240 |
Why?
|
| Diarylheptanoids | 1 | 2023 | 2 | 0.230 |
Why?
|
| Photochemotherapy | 2 | 2015 | 96 | 0.230 |
Why?
|
| Osteosarcoma | 3 | 2022 | 929 | 0.230 |
Why?
|
| HCT116 Cells | 5 | 2019 | 348 | 0.230 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 1270 | 0.230 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2024 | 142 | 0.230 |
Why?
|
| RNA, Small Nucleolar | 1 | 2023 | 25 | 0.230 |
Why?
|
| Inhibitor of Apoptosis Proteins | 4 | 2011 | 202 | 0.230 |
Why?
|
| Autocrine Communication | 3 | 2018 | 84 | 0.230 |
Why?
|
| Osteoblasts | 3 | 2016 | 370 | 0.230 |
Why?
|
| Proteome | 3 | 2019 | 561 | 0.230 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2013 | 461 | 0.230 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2004 | 214 | 0.220 |
Why?
|
| Heat-Shock Proteins | 2 | 2014 | 311 | 0.220 |
Why?
|
| Immunoenzyme Techniques | 4 | 2016 | 1165 | 0.220 |
Why?
|
| Methyltransferases | 2 | 2022 | 148 | 0.220 |
Why?
|
| Lipolysis | 1 | 2023 | 108 | 0.220 |
Why?
|
| Ribose | 1 | 2022 | 32 | 0.220 |
Why?
|
| Neovascularization, Physiologic | 2 | 2019 | 345 | 0.220 |
Why?
|
| Insulin Resistance | 1 | 2008 | 731 | 0.220 |
Why?
|
| Anthracyclines | 2 | 2023 | 331 | 0.220 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2017 | 383 | 0.220 |
Why?
|
| Gene Regulatory Networks | 3 | 2016 | 677 | 0.220 |
Why?
|
| Kynurenine | 1 | 2023 | 71 | 0.220 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2022 | 35 | 0.220 |
Why?
|
| Ataxia Telangiectasia | 1 | 2023 | 62 | 0.220 |
Why?
|
| Adenosine Diphosphate | 1 | 2022 | 113 | 0.220 |
Why?
|
| E2F3 Transcription Factor | 1 | 2022 | 23 | 0.220 |
Why?
|
| CD47 Antigen | 1 | 2022 | 26 | 0.210 |
Why?
|
| Alternative Splicing | 2 | 2016 | 584 | 0.210 |
Why?
|
| F-Box Proteins | 2 | 2013 | 96 | 0.210 |
Why?
|
| Transcription Factor RelA | 2 | 2015 | 184 | 0.210 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2020 | 154 | 0.210 |
Why?
|
| Ubiquitin-Specific Proteases | 3 | 2018 | 73 | 0.210 |
Why?
|
| Adaptive Immunity | 1 | 2023 | 149 | 0.210 |
Why?
|
| A549 Cells | 2 | 2019 | 124 | 0.210 |
Why?
|
| Ecosystem | 1 | 2023 | 111 | 0.210 |
Why?
|
| Receptors, Androgen | 2 | 2005 | 878 | 0.210 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 2022 | 27 | 0.210 |
Why?
|
| Taxoids | 3 | 2017 | 967 | 0.210 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2022 | 61 | 0.210 |
Why?
|
| Second Messenger Systems | 1 | 2002 | 39 | 0.210 |
Why?
|
| Erythropoietin | 2 | 2015 | 205 | 0.210 |
Why?
|
| Drug Synergism | 6 | 2019 | 1313 | 0.210 |
Why?
|
| Predictive Value of Tests | 5 | 2022 | 4892 | 0.210 |
Why?
|
| Chromones | 3 | 2010 | 120 | 0.210 |
Why?
|
| CHO Cells | 3 | 2007 | 311 | 0.210 |
Why?
|
| Polyploidy | 1 | 2022 | 73 | 0.210 |
Why?
|
| Membrane Glycoproteins | 2 | 2016 | 1073 | 0.210 |
Why?
|
| Anoikis | 3 | 2019 | 63 | 0.210 |
Why?
|
| Ribotyping | 1 | 2022 | 48 | 0.200 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 25 | 0.200 |
Why?
|
| Spliceosomes | 1 | 2022 | 75 | 0.200 |
Why?
|
| Viral Regulatory and Accessory Proteins | 3 | 2015 | 64 | 0.200 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 538 | 0.200 |
Why?
|
| Fluorescent Antibody Technique | 8 | 2021 | 1062 | 0.200 |
Why?
|
| Caveolin 1 | 2 | 2017 | 204 | 0.200 |
Why?
|
| Scutellaria | 1 | 2021 | 6 | 0.200 |
Why?
|
| Cyclooxygenase 2 | 3 | 2013 | 483 | 0.200 |
Why?
|
| Phenylketonurias | 1 | 2021 | 23 | 0.200 |
Why?
|
| Endosomes | 3 | 2006 | 109 | 0.200 |
Why?
|
| Ceramides | 1 | 2002 | 95 | 0.200 |
Why?
|
| Asparagine | 1 | 2021 | 38 | 0.200 |
Why?
|
| Niacinamide | 3 | 2020 | 421 | 0.200 |
Why?
|
| Brain | 2 | 2020 | 4113 | 0.200 |
Why?
|
| Rats | 7 | 2013 | 6086 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2022 | 272 | 0.200 |
Why?
|
| Phenylalanine | 1 | 2021 | 142 | 0.200 |
Why?
|
| Interleukin-18 | 1 | 2021 | 100 | 0.200 |
Why?
|
| Muscle Development | 1 | 2021 | 88 | 0.200 |
Why?
|
| Nucleic Acid Conformation | 4 | 2021 | 279 | 0.200 |
Why?
|
| GTP-Binding Proteins | 1 | 2022 | 321 | 0.200 |
Why?
|
| Cell Migration Assays | 1 | 2020 | 11 | 0.190 |
Why?
|
| Enzyme Stability | 3 | 2009 | 105 | 0.190 |
Why?
|
| Lysosomes | 2 | 2023 | 347 | 0.190 |
Why?
|
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2020 | 29 | 0.190 |
Why?
|
| Paracrine Communication | 2 | 2018 | 128 | 0.190 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2016 | 925 | 0.190 |
Why?
|
| Middle Aged | 27 | 2022 | 86204 | 0.190 |
Why?
|
| Mass Spectrometry | 5 | 2010 | 702 | 0.190 |
Why?
|
| Receptors, Virus | 1 | 2021 | 157 | 0.190 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 235 | 0.190 |
Why?
|
| Carcinogens | 2 | 2017 | 384 | 0.190 |
Why?
|
| Protease Inhibitors | 1 | 2022 | 210 | 0.190 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2021 | 192 | 0.190 |
Why?
|
| Muscular Dystrophies | 1 | 2020 | 51 | 0.190 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2020 | 21 | 0.190 |
Why?
|
| Adenosine A1 Receptor Antagonists | 1 | 2020 | 5 | 0.190 |
Why?
|
| Recombinant Proteins | 9 | 2016 | 2927 | 0.190 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2020 | 6 | 0.190 |
Why?
|
| Nanoparticles | 2 | 2017 | 554 | 0.190 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 126 | 0.190 |
Why?
|
| Tissue Array Analysis | 3 | 2020 | 760 | 0.190 |
Why?
|
| Antibody Specificity | 2 | 2019 | 334 | 0.190 |
Why?
|
| Myocarditis | 1 | 2022 | 190 | 0.190 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2020 | 31 | 0.180 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2022 | 167 | 0.180 |
Why?
|
| Small Molecule Libraries | 2 | 2019 | 169 | 0.180 |
Why?
|
| Deoxycytidine | 2 | 2018 | 1353 | 0.180 |
Why?
|
| N-Terminal Acetyltransferase A | 2 | 2010 | 14 | 0.180 |
Why?
|
| N-Terminal Acetyltransferase E | 2 | 2010 | 14 | 0.180 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 300 | 0.180 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2020 | 78 | 0.180 |
Why?
|
| Lipogenesis | 1 | 2020 | 76 | 0.180 |
Why?
|
| Indolizines | 1 | 2019 | 45 | 0.180 |
Why?
|
| bcl-X Protein | 3 | 2011 | 196 | 0.180 |
Why?
|
| Tankyrases | 1 | 2019 | 9 | 0.180 |
Why?
|
| Glycoside Hydrolases | 1 | 2019 | 37 | 0.180 |
Why?
|
| Mixed Function Oxygenases | 1 | 2019 | 64 | 0.180 |
Why?
|
| Threonine | 3 | 2011 | 161 | 0.180 |
Why?
|
| Pyridinium Compounds | 1 | 2019 | 63 | 0.180 |
Why?
|
| Immunomodulation | 1 | 2021 | 242 | 0.180 |
Why?
|
| Immune System | 1 | 2021 | 279 | 0.180 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2019 | 7 | 0.180 |
Why?
|
| RNA, Neoplasm | 3 | 2017 | 771 | 0.180 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 2 | 2010 | 96 | 0.180 |
Why?
|
| Aminohydrolases | 1 | 2019 | 7 | 0.180 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2018 | 216 | 0.180 |
Why?
|
| Oligonucleotides | 1 | 2020 | 227 | 0.180 |
Why?
|
| Multifunctional Enzymes | 1 | 2019 | 12 | 0.180 |
Why?
|
| Cyclic N-Oxides | 1 | 2019 | 106 | 0.170 |
Why?
|
| Gluconeogenesis | 1 | 2020 | 121 | 0.170 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 309 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 2 | 2019 | 545 | 0.170 |
Why?
|
| Vimentin | 2 | 2010 | 253 | 0.170 |
Why?
|
| Radiation, Ionizing | 3 | 2016 | 187 | 0.170 |
Why?
|
| Palmitates | 1 | 2018 | 23 | 0.170 |
Why?
|
| Adipocytes | 2 | 2023 | 305 | 0.170 |
Why?
|
| Coatomer Protein | 1 | 2019 | 35 | 0.170 |
Why?
|
| Hep G2 Cells | 3 | 2016 | 155 | 0.170 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2019 | 72 | 0.170 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 558 | 0.170 |
Why?
|
| Glioma | 2 | 2023 | 1963 | 0.170 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 131 | 0.170 |
Why?
|
| Homozygote | 2 | 2018 | 717 | 0.170 |
Why?
|
| Muscle Proteins | 2 | 2020 | 549 | 0.170 |
Why?
|
| False Negative Reactions | 1 | 2019 | 275 | 0.170 |
Why?
|
| Genes, bcl-1 | 3 | 2011 | 24 | 0.170 |
Why?
|
| Thiolester Hydrolases | 1 | 2019 | 34 | 0.170 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 6009 | 0.170 |
Why?
|
| Glutamates | 1 | 2019 | 130 | 0.170 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2014 | 1299 | 0.170 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2018 | 38 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2020 | 10035 | 0.170 |
Why?
|
| Granzymes | 1 | 2019 | 91 | 0.170 |
Why?
|
| Necrosis | 1 | 2020 | 580 | 0.170 |
Why?
|
| Benzylidene Compounds | 1 | 2018 | 9 | 0.170 |
Why?
|
| Pyrrolidinones | 1 | 2019 | 61 | 0.170 |
Why?
|
| Growth Inhibitors | 1 | 1999 | 149 | 0.170 |
Why?
|
| Protein Methyltransferases | 2 | 2011 | 45 | 0.170 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2019 | 92 | 0.170 |
Why?
|
| Autoantigens | 2 | 2019 | 234 | 0.170 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 3 | 2005 | 87 | 0.160 |
Why?
|
| Inflammatory Breast Neoplasms | 2 | 2014 | 509 | 0.160 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2018 | 35 | 0.160 |
Why?
|
| Limit of Detection | 1 | 2018 | 78 | 0.160 |
Why?
|
| Antigen Presentation | 1 | 2019 | 272 | 0.160 |
Why?
|
| DNA Primers | 5 | 2010 | 1399 | 0.160 |
Why?
|
| Racism | 1 | 2019 | 50 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 2195 | 0.160 |
Why?
|
| Triazines | 1 | 2019 | 117 | 0.160 |
Why?
|
| Dendritic Cells | 2 | 2022 | 1085 | 0.160 |
Why?
|
| ADP-Ribosylation | 1 | 2017 | 2 | 0.160 |
Why?
|
| RecQ Helicases | 1 | 2018 | 102 | 0.160 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2018 | 46 | 0.160 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2018 | 109 | 0.160 |
Why?
|
| Mice, Inbred Strains | 2 | 2010 | 521 | 0.160 |
Why?
|
| Tumor Burden | 6 | 2016 | 1987 | 0.160 |
Why?
|
| Actin Cytoskeleton | 1 | 2018 | 82 | 0.160 |
Why?
|
| Caveolae | 1 | 2017 | 20 | 0.160 |
Why?
|
| Lung | 4 | 2023 | 3151 | 0.160 |
Why?
|
| Hydroxamic Acids | 2 | 2010 | 442 | 0.160 |
Why?
|
| Models, Immunological | 1 | 2017 | 77 | 0.150 |
Why?
|
| Caspase 3 | 4 | 2012 | 471 | 0.150 |
Why?
|
| Antigens, Surface | 1 | 2018 | 295 | 0.150 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2018 | 100 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 388 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 2 | 2008 | 15 | 0.150 |
Why?
|
| Chromatin | 4 | 2012 | 942 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 769 | 0.150 |
Why?
|
| Adenine | 1 | 2020 | 631 | 0.150 |
Why?
|
| Stilbenes | 2 | 2016 | 86 | 0.150 |
Why?
|
| Lymphotoxin-beta | 1 | 2017 | 3 | 0.150 |
Why?
|
| PPAR gamma | 2 | 2011 | 229 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2013 | 566 | 0.150 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 663 | 0.150 |
Why?
|
| RNAi Therapeutics | 1 | 2017 | 42 | 0.150 |
Why?
|
| Guanylate Cyclase | 1 | 2017 | 74 | 0.150 |
Why?
|
| Dysbiosis | 1 | 2018 | 134 | 0.150 |
Why?
|
| Bacteria | 1 | 2022 | 611 | 0.150 |
Why?
|
| NADPH Oxidase 4 | 1 | 2017 | 23 | 0.150 |
Why?
|
| Receptors, IgE | 1 | 2017 | 39 | 0.150 |
Why?
|
| Dendrites | 1 | 2018 | 196 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 224 | 0.150 |
Why?
|
| Neoplasms, Hormone-Dependent | 3 | 2014 | 342 | 0.150 |
Why?
|
| Luciferases | 5 | 2016 | 445 | 0.150 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2017 | 43 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2017 | 48 | 0.150 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2017 | 56 | 0.150 |
Why?
|
| Structure-Activity Relationship | 7 | 2017 | 931 | 0.150 |
Why?
|
| Nipples | 4 | 2005 | 132 | 0.150 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2016 | 19 | 0.150 |
Why?
|
| Aniline Compounds | 1 | 2018 | 177 | 0.150 |
Why?
|
| Imatinib Mesylate | 1 | 2021 | 1665 | 0.150 |
Why?
|
| Random Allocation | 2 | 2019 | 703 | 0.150 |
Why?
|
| COP9 Signalosome Complex | 1 | 2016 | 72 | 0.150 |
Why?
|
| Norepinephrine | 1 | 2017 | 272 | 0.150 |
Why?
|
| Non-Fibrillar Collagens | 1 | 2016 | 3 | 0.140 |
Why?
|
| Argininosuccinate Synthase | 1 | 2016 | 54 | 0.140 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2017 | 53 | 0.140 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 183 | 0.140 |
Why?
|
| Osteogenesis | 3 | 2016 | 271 | 0.140 |
Why?
|
| Epinephrine | 1 | 2017 | 255 | 0.140 |
Why?
|
| Adult | 20 | 2020 | 77950 | 0.140 |
Why?
|
| GRB2 Adaptor Protein | 2 | 2015 | 52 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 673 | 0.140 |
Why?
|
| Lymphatic Metastasis | 7 | 2016 | 4844 | 0.140 |
Why?
|
| Treatment Outcome | 10 | 2021 | 32848 | 0.140 |
Why?
|
| Aged | 18 | 2022 | 70117 | 0.140 |
Why?
|
| PPAR delta | 1 | 2017 | 55 | 0.140 |
Why?
|
| Survival Rate | 7 | 2019 | 12221 | 0.140 |
Why?
|
| Receptors, Notch | 1 | 2019 | 383 | 0.140 |
Why?
|
| Cattle | 1 | 2018 | 783 | 0.140 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2017 | 93 | 0.140 |
Why?
|
| Pyrimidinones | 1 | 2018 | 314 | 0.140 |
Why?
|
| Stem Cell Factor | 1 | 2016 | 87 | 0.140 |
Why?
|
| Cricetulus | 2 | 2007 | 205 | 0.140 |
Why?
|
| Aerobiosis | 1 | 2016 | 30 | 0.140 |
Why?
|
| Oxidative Stress | 2 | 2019 | 1129 | 0.140 |
Why?
|
| Catalysis | 1 | 2016 | 250 | 0.140 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2017 | 113 | 0.140 |
Why?
|
| Ephrin-A1 | 1 | 2015 | 3 | 0.140 |
Why?
|
| CD24 Antigen | 2 | 2017 | 85 | 0.140 |
Why?
|
| Phenylurea Compounds | 2 | 2011 | 580 | 0.140 |
Why?
|
| Smad2 Protein | 1 | 2016 | 89 | 0.140 |
Why?
|
| HSP27 Heat-Shock Proteins | 2 | 2012 | 33 | 0.140 |
Why?
|
| Cytosol | 1 | 2016 | 238 | 0.140 |
Why?
|
| Quality Control | 2 | 2016 | 457 | 0.140 |
Why?
|
| Curcumin | 1 | 2016 | 117 | 0.140 |
Why?
|
| Drug Resistance, Multiple | 1 | 1996 | 204 | 0.140 |
Why?
|
| Estradiol | 3 | 2022 | 748 | 0.140 |
Why?
|
| Receptor, EphB4 | 1 | 2015 | 27 | 0.140 |
Why?
|
| Body Fluids | 3 | 2005 | 125 | 0.130 |
Why?
|
| Protein Folding | 2 | 2019 | 281 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 4 | 2011 | 287 | 0.130 |
Why?
|
| Phospholipase C gamma | 1 | 2015 | 54 | 0.130 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 524 | 0.130 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2015 | 12 | 0.130 |
Why?
|
| Microscopy | 1 | 2016 | 182 | 0.130 |
Why?
|
| Glutathione Transferase | 4 | 2011 | 359 | 0.130 |
Why?
|
| Integrin beta Chains | 1 | 2015 | 34 | 0.130 |
Why?
|
| Microbiota | 1 | 2022 | 547 | 0.130 |
Why?
|
| Receptors, Progesterone | 2 | 2019 | 1392 | 0.130 |
Why?
|
| Kidney | 3 | 2019 | 2146 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 323 | 0.130 |
Why?
|
| Cell Transdifferentiation | 1 | 2016 | 112 | 0.130 |
Why?
|
| Oncogene Protein v-akt | 1 | 2015 | 101 | 0.130 |
Why?
|
| Plasmids | 3 | 2009 | 837 | 0.130 |
Why?
|
| Glucose | 4 | 2022 | 1248 | 0.130 |
Why?
|
| Colitis | 1 | 2018 | 340 | 0.130 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2005 | 208 | 0.130 |
Why?
|
| Ki-67 Antigen | 2 | 2009 | 666 | 0.130 |
Why?
|
| Intestines | 1 | 2019 | 686 | 0.130 |
Why?
|
| Lentivirus | 2 | 2013 | 169 | 0.130 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2016 | 299 | 0.130 |
Why?
|
| Calibration | 1 | 2016 | 337 | 0.130 |
Why?
|
| Hyaluronan Receptors | 2 | 2017 | 249 | 0.130 |
Why?
|
| Mediator Complex | 2 | 2013 | 69 | 0.130 |
Why?
|
| Cortactin | 1 | 2014 | 6 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2015 | 96 | 0.130 |
Why?
|
| Imidazoles | 2 | 2019 | 999 | 0.130 |
Why?
|
| Histone Acetyltransferases | 1 | 2017 | 411 | 0.130 |
Why?
|
| COS Cells | 2 | 2005 | 377 | 0.130 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2016 | 146 | 0.130 |
Why?
|
| United States | 5 | 2022 | 15433 | 0.130 |
Why?
|
| Glutamine | 1 | 2016 | 299 | 0.130 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2015 | 153 | 0.130 |
Why?
|
| Substrate Specificity | 3 | 2021 | 549 | 0.130 |
Why?
|
| Aged, 80 and over | 8 | 2019 | 29902 | 0.130 |
Why?
|
| Genomic Instability | 2 | 2015 | 519 | 0.130 |
Why?
|
| Conserved Sequence | 2 | 2009 | 469 | 0.130 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2015 | 126 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 476 | 0.130 |
Why?
|
| Sarcoma | 3 | 2010 | 1725 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 292 | 0.130 |
Why?
|
| Plasminogen Activators | 1 | 2014 | 52 | 0.120 |
Why?
|
| Interferon-alpha | 1 | 1999 | 889 | 0.120 |
Why?
|
| Histone Demethylases | 1 | 2016 | 144 | 0.120 |
Why?
|
| DNA, Viral | 1 | 1997 | 694 | 0.120 |
Why?
|
| Candidiasis | 1 | 2017 | 262 | 0.120 |
Why?
|
| Adipogenesis | 2 | 2016 | 105 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2012 | 1152 | 0.120 |
Why?
|
| Aurora Kinases | 4 | 2012 | 189 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 479 | 0.120 |
Why?
|
| Cells | 1 | 2014 | 31 | 0.120 |
Why?
|
| Optical Imaging | 1 | 2015 | 157 | 0.120 |
Why?
|
| Mutant Proteins | 2 | 2014 | 234 | 0.120 |
Why?
|
| Cell Engineering | 1 | 2014 | 37 | 0.120 |
Why?
|
| Phthalazines | 1 | 2016 | 253 | 0.120 |
Why?
|
| Molecular Conformation | 1 | 2014 | 171 | 0.120 |
Why?
|
| Bcl-2-Like Protein 11 | 2 | 2010 | 65 | 0.120 |
Why?
|
| Minichromosome Maintenance Complex Component 7 | 1 | 2013 | 14 | 0.120 |
Why?
|
| G1 Phase | 4 | 2015 | 285 | 0.120 |
Why?
|
| Caspase Inhibitors | 2 | 2005 | 95 | 0.120 |
Why?
|
| Sulfones | 2 | 2019 | 143 | 0.120 |
Why?
|
| Fluorescence | 1 | 2014 | 195 | 0.120 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2019 | 923 | 0.120 |
Why?
|
| ras Proteins | 2 | 2012 | 770 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2017 | 280 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2007 | 997 | 0.120 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2015 | 448 | 0.120 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2013 | 7 | 0.120 |
Why?
|
| Rectal Neoplasms | 1 | 2022 | 1202 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2009 | 568 | 0.110 |
Why?
|
| Phenotype | 7 | 2019 | 6295 | 0.110 |
Why?
|
| Actins | 2 | 2019 | 608 | 0.110 |
Why?
|
| Dyneins | 1 | 2013 | 31 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2007 | 630 | 0.110 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 355 | 0.110 |
Why?
|
| bcl-2-Associated X Protein | 3 | 2015 | 367 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 1618 | 0.110 |
Why?
|
| Cysteine Endopeptidases | 2 | 2004 | 251 | 0.110 |
Why?
|
| 3' Untranslated Regions | 3 | 2024 | 343 | 0.110 |
Why?
|
| SOX9 Transcription Factor | 1 | 2014 | 170 | 0.110 |
Why?
|
| Cations | 2 | 2004 | 62 | 0.110 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2015 | 167 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2013 | 153 | 0.110 |
Why?
|
| Peptide Fragments | 2 | 2016 | 1271 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2013 | 23 | 0.110 |
Why?
|
| Smad3 Protein | 1 | 2014 | 129 | 0.110 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2012 | 19 | 0.110 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 126 | 0.110 |
Why?
|
| Cisplatin | 3 | 2013 | 2432 | 0.110 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 554 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 3 | 2017 | 3976 | 0.110 |
Why?
|
| Cdc20 Proteins | 2 | 2003 | 25 | 0.110 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2013 | 113 | 0.110 |
Why?
|
| RNA Precursors | 1 | 2013 | 137 | 0.110 |
Why?
|
| Digitonin | 1 | 2012 | 4 | 0.110 |
Why?
|
| Peptides | 4 | 2012 | 1479 | 0.110 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2012 | 40 | 0.110 |
Why?
|
| Cell Size | 2 | 2011 | 136 | 0.110 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 162 | 0.110 |
Why?
|
| Interleukin-8 | 2 | 2017 | 519 | 0.110 |
Why?
|
| Indicators and Reagents | 1 | 2012 | 128 | 0.110 |
Why?
|
| Heterozygote | 2 | 2018 | 1020 | 0.100 |
Why?
|
| Neoplasm Staging | 4 | 2014 | 13658 | 0.100 |
Why?
|
| Catalytic Domain | 2 | 2004 | 303 | 0.100 |
Why?
|
| APOBEC-3G Deaminase | 1 | 2011 | 6 | 0.100 |
Why?
|
| Claudin-4 | 1 | 2011 | 11 | 0.100 |
Why?
|
| Cell Membrane Permeability | 1 | 2012 | 122 | 0.100 |
Why?
|
| Protein Sorting Signals | 1 | 2011 | 44 | 0.100 |
Why?
|
| Cell Compartmentation | 1 | 2011 | 76 | 0.100 |
Why?
|
| Feedback, Physiological | 2 | 2020 | 193 | 0.100 |
Why?
|
| Genes, erbB-1 | 1 | 2012 | 101 | 0.100 |
Why?
|
| Tunicamycin | 1 | 2011 | 20 | 0.100 |
Why?
|
| Dioxoles | 1 | 2011 | 19 | 0.100 |
Why?
|
| Interleukin-1alpha | 1 | 2012 | 56 | 0.100 |
Why?
|
| Indoles | 2 | 2016 | 1009 | 0.100 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2012 | 107 | 0.100 |
Why?
|
| Aneuploidy | 2 | 2011 | 369 | 0.100 |
Why?
|
| RNA Polymerase I | 1 | 2011 | 19 | 0.100 |
Why?
|
| Receptors, Estrogen | 5 | 2010 | 2086 | 0.100 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 60 | 0.100 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2014 | 323 | 0.100 |
Why?
|
| Patient Selection | 1 | 2019 | 2055 | 0.100 |
Why?
|
| Entosis | 1 | 2011 | 4 | 0.100 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2009 | 1216 | 0.100 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 123 | 0.100 |
Why?
|
| Zinc Finger Protein Gli2 | 3 | 2015 | 30 | 0.100 |
Why?
|
| Dystrophin | 2 | 2021 | 41 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2010 | 287 | 0.100 |
Why?
|
| DNA, Ribosomal | 1 | 2011 | 103 | 0.100 |
Why?
|
| 2-Aminopurine | 1 | 2010 | 9 | 0.100 |
Why?
|
| 4-Butyrolactone | 1 | 2010 | 8 | 0.100 |
Why?
|
| Retinoblastoma Protein | 2 | 2003 | 335 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2004 | 243 | 0.100 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2006 | 94 | 0.100 |
Why?
|
| Quassins | 1 | 2010 | 3 | 0.100 |
Why?
|
| Fatty Acid Synthases | 1 | 2010 | 24 | 0.100 |
Why?
|
| Leupeptins | 3 | 2006 | 68 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 216 | 0.100 |
Why?
|
| Zinc Fingers | 2 | 2018 | 205 | 0.100 |
Why?
|
| Cytokinesis | 1 | 2011 | 57 | 0.100 |
Why?
|
| Thiazoles | 2 | 2014 | 726 | 0.100 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2010 | 20 | 0.100 |
Why?
|
| Gene Deletion | 3 | 2019 | 1442 | 0.100 |
Why?
|
| Centrosome | 1 | 2011 | 95 | 0.100 |
Why?
|
| Chlorpropamide | 1 | 2010 | 2 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 256 | 0.100 |
Why?
|
| CREB-Binding Protein | 2 | 2009 | 86 | 0.100 |
Why?
|
| Protein Array Analysis | 4 | 2010 | 501 | 0.090 |
Why?
|
| Quantum Dots | 1 | 2010 | 30 | 0.090 |
Why?
|
| Withanolides | 1 | 2010 | 3 | 0.090 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 190 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2013 | 324 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 5 | 2017 | 3203 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 644 | 0.090 |
Why?
|
| Rad51 Recombinase | 1 | 2011 | 126 | 0.090 |
Why?
|
| Quinolones | 1 | 2011 | 160 | 0.090 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2010 | 44 | 0.090 |
Why?
|
| Chelating Agents | 1 | 2011 | 127 | 0.090 |
Why?
|
| HT29 Cells | 1 | 2010 | 159 | 0.090 |
Why?
|
| Neoadjuvant Therapy | 2 | 2022 | 4975 | 0.090 |
Why?
|
| Mice, Inbred C3H | 2 | 2002 | 385 | 0.090 |
Why?
|
| Diethylstilbestrol | 1 | 2010 | 109 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 301 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 2796 | 0.090 |
Why?
|
| Xanthones | 1 | 2009 | 7 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 79 | 0.090 |
Why?
|
| Furans | 1 | 2010 | 104 | 0.090 |
Why?
|
| Integrin beta1 | 2 | 2013 | 126 | 0.090 |
Why?
|
| Oxidation-Reduction | 3 | 2019 | 717 | 0.090 |
Why?
|
| Prodrugs | 1 | 2011 | 217 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 907 | 0.090 |
Why?
|
| Receptor, PAR-1 | 1 | 2009 | 33 | 0.090 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 4654 | 0.090 |
Why?
|
| Phosphodiesterase I | 1 | 2009 | 20 | 0.090 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2009 | 70 | 0.090 |
Why?
|
| Epoxy Compounds | 1 | 2009 | 55 | 0.090 |
Why?
|
| Dasatinib | 3 | 2023 | 862 | 0.090 |
Why?
|
| Lignans | 1 | 2009 | 15 | 0.090 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2010 | 160 | 0.090 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2009 | 104 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2013 | 492 | 0.090 |
Why?
|
| Pyrophosphatases | 1 | 2009 | 51 | 0.090 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2014 | 425 | 0.090 |
Why?
|
| Multivariate Analysis | 4 | 2015 | 4298 | 0.090 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2009 | 80 | 0.090 |
Why?
|
| Homeostasis | 2 | 2019 | 950 | 0.090 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 329 | 0.090 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 103 | 0.080 |
Why?
|
| Piperazines | 2 | 2016 | 2101 | 0.080 |
Why?
|
| DNA End-Joining Repair | 2 | 2022 | 86 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 3 | 2016 | 577 | 0.080 |
Why?
|
| Mice, Obese | 1 | 2008 | 104 | 0.080 |
Why?
|
| Cell Communication | 3 | 2019 | 509 | 0.080 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2008 | 21 | 0.080 |
Why?
|
| Consensus Sequence | 2 | 2007 | 117 | 0.080 |
Why?
|
| Fibroblasts | 4 | 2020 | 1682 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2008 | 132 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2009 | 191 | 0.080 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2008 | 51 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 2063 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 88 | 0.080 |
Why?
|
| Algorithms | 4 | 2024 | 3890 | 0.080 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 3 | 2014 | 159 | 0.080 |
Why?
|
| Tetracycline | 2 | 2006 | 90 | 0.080 |
Why?
|
| Swiss 3T3 Cells | 1 | 2007 | 5 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2011 | 668 | 0.080 |
Why?
|
| Molecular Structure | 3 | 2010 | 515 | 0.080 |
Why?
|
| Genes, myc | 1 | 2009 | 358 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2024 | 37905 | 0.080 |
Why?
|
| Mice, Mutant Strains | 3 | 2020 | 634 | 0.080 |
Why?
|
| Receptors, Cholecystokinin | 1 | 2007 | 29 | 0.080 |
Why?
|
| Prostate | 1 | 2013 | 1088 | 0.080 |
Why?
|
| DNA Copy Number Variations | 2 | 2017 | 1516 | 0.080 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2019 | 110 | 0.080 |
Why?
|
| Astrocytes | 1 | 2011 | 368 | 0.080 |
Why?
|
| Galectin 3 | 1 | 2009 | 138 | 0.080 |
Why?
|
| Models, Molecular | 4 | 2017 | 1732 | 0.080 |
Why?
|
| Aging | 1 | 2016 | 1582 | 0.080 |
Why?
|
| cdc25 Phosphatases | 1 | 2008 | 97 | 0.080 |
Why?
|
| Time Factors | 7 | 2017 | 12926 | 0.080 |
Why?
|
| Guanidines | 1 | 2007 | 60 | 0.080 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2017 | 164 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2018 | 987 | 0.070 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2007 | 84 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2016 | 1471 | 0.070 |
Why?
|
| Staurosporine | 1 | 2007 | 143 | 0.070 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2007 | 60 | 0.070 |
Why?
|
| Pyrimidines | 3 | 2020 | 3518 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2010 | 682 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 1021 | 0.070 |
Why?
|
| Equipment Design | 1 | 2010 | 1204 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2006 | 196 | 0.070 |
Why?
|
| Nuclear Export Signals | 1 | 2006 | 10 | 0.070 |
Why?
|
| Blood-Brain Barrier | 1 | 2007 | 238 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 500 | 0.070 |
Why?
|
| Operon | 1 | 2006 | 53 | 0.070 |
Why?
|
| Carcinogenicity Tests | 1 | 2006 | 70 | 0.070 |
Why?
|
| Clathrin | 1 | 2005 | 34 | 0.070 |
Why?
|
| Vitronectin | 1 | 2005 | 22 | 0.070 |
Why?
|
| Transcription Factor AP-2 | 1 | 2006 | 79 | 0.070 |
Why?
|
| Genomics | 2 | 2008 | 2738 | 0.070 |
Why?
|
| Myocytes, Cardiac | 2 | 2022 | 764 | 0.070 |
Why?
|
| ran GTP-Binding Protein | 1 | 2005 | 34 | 0.070 |
Why?
|
| Integrin alphaV | 1 | 2005 | 20 | 0.070 |
Why?
|
| Genes, BRCA1 | 1 | 2008 | 387 | 0.070 |
Why?
|
| Adenovirus E1B Proteins | 1 | 2005 | 22 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2006 | 94 | 0.070 |
Why?
|
| Dogs | 1 | 2007 | 1155 | 0.070 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 2005 | 16 | 0.070 |
Why?
|
| Thionucleotides | 1 | 2005 | 65 | 0.070 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2005 | 40 | 0.070 |
Why?
|
| Esophagus | 1 | 2009 | 553 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2014 | 1217 | 0.070 |
Why?
|
| Genes, fos | 1 | 2005 | 53 | 0.070 |
Why?
|
| Vaccines, Attenuated | 1 | 2006 | 210 | 0.070 |
Why?
|
| Oleanolic Acid | 1 | 2006 | 108 | 0.070 |
Why?
|
| Antigens, CD | 4 | 2014 | 1385 | 0.070 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2005 | 15 | 0.070 |
Why?
|
| Bystander Effect | 1 | 2005 | 23 | 0.070 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2010 | 840 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 4320 | 0.060 |
Why?
|
| Gastroesophageal Reflux | 1 | 2008 | 334 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2008 | 1391 | 0.060 |
Why?
|
| Leukemia, Myeloid | 1 | 2010 | 941 | 0.060 |
Why?
|
| Kinetics | 1 | 2008 | 2049 | 0.060 |
Why?
|
| Genes, Bacterial | 1 | 2006 | 236 | 0.060 |
Why?
|
| Protein Precursors | 2 | 1996 | 240 | 0.060 |
Why?
|
| Mice, Inbred ICR | 2 | 2013 | 239 | 0.060 |
Why?
|
| Lithium | 1 | 2004 | 71 | 0.060 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2004 | 97 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 189 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2006 | 2232 | 0.060 |
Why?
|
| p21-Activated Kinases | 1 | 2005 | 122 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2009 | 1213 | 0.060 |
Why?
|
| Half-Life | 2 | 2020 | 259 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2005 | 209 | 0.060 |
Why?
|
| Risk Factors | 6 | 2017 | 17523 | 0.060 |
Why?
|
| Genomic Library | 1 | 2004 | 41 | 0.060 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2005 | 205 | 0.060 |
Why?
|
| Genes, jun | 1 | 2004 | 41 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 261 | 0.060 |
Why?
|
| U937 Cells | 2 | 2017 | 171 | 0.060 |
Why?
|
| Liver | 3 | 2021 | 2961 | 0.060 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2004 | 108 | 0.060 |
Why?
|
| Asymmetric Cell Division | 1 | 2024 | 11 | 0.060 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2005 | 155 | 0.060 |
Why?
|
| Flow Cytometry | 4 | 2016 | 3033 | 0.060 |
Why?
|
| Neutrophils | 2 | 2020 | 835 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 1037 | 0.060 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 2 | 2014 | 40 | 0.060 |
Why?
|
| Computational Biology | 2 | 2014 | 1271 | 0.060 |
Why?
|
| Genes, Dominant | 2 | 2004 | 331 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2011 | 2508 | 0.060 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2004 | 167 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2006 | 403 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2005 | 196 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 4971 | 0.060 |
Why?
|
| Cyclin B1 | 1 | 2003 | 56 | 0.060 |
Why?
|
| High-Temperature Requirement A Serine Peptidase 1 | 1 | 2023 | 9 | 0.060 |
Why?
|
| Recurrence | 2 | 2023 | 4758 | 0.060 |
Why?
|
| Alleles | 1 | 2010 | 2437 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 875 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2006 | 467 | 0.060 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2023 | 25 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 1960 | 0.060 |
Why?
|
| Receptors, Erythropoietin | 2 | 2015 | 70 | 0.060 |
Why?
|
| Nitriles | 1 | 2008 | 906 | 0.060 |
Why?
|
| Cyclin B | 1 | 2003 | 63 | 0.060 |
Why?
|
| Myelopoiesis | 1 | 2023 | 31 | 0.060 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2010 | 882 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2009 | 394 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2005 | 441 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 1819 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2023 | 182 | 0.060 |
Why?
|
| Cytomegalovirus | 1 | 2006 | 482 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 2 | 2013 | 435 | 0.060 |
Why?
|
| Germ-Line Mutation | 2 | 2008 | 1046 | 0.060 |
Why?
|
| Cystadenocarcinoma, Papillary | 1 | 2003 | 82 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2013 | 1797 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2023 | 114 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2012 | 4938 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2005 | 429 | 0.050 |
Why?
|
| Rejuvenation | 1 | 2023 | 72 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2005 | 574 | 0.050 |
Why?
|
| MRE11 Homologue Protein | 1 | 2022 | 39 | 0.050 |
Why?
|
| Sp1 Transcription Factor | 1 | 2003 | 188 | 0.050 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2022 | 50 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2022 | 109 | 0.050 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2002 | 25 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2023 | 259 | 0.050 |
Why?
|
| Genes, Retinoblastoma | 1 | 2022 | 86 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 3022 | 0.050 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2022 | 84 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2023 | 203 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2023 | 185 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2002 | 64 | 0.050 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 18 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 4 | 2005 | 248 | 0.050 |
Why?
|
| Estrogen Receptor beta | 1 | 2022 | 155 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2006 | 1544 | 0.050 |
Why?
|
| MARVEL Domain-Containing Proteins | 1 | 2021 | 3 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 4988 | 0.050 |
Why?
|
| Diet, Ketogenic | 1 | 2021 | 22 | 0.050 |
Why?
|
| Antipyrine | 1 | 2020 | 8 | 0.050 |
Why?
|
| Lymph Nodes | 2 | 2015 | 2967 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 289 | 0.050 |
Why?
|
| Mice, Inbred mdx | 1 | 2020 | 44 | 0.050 |
Why?
|
| Tripartite Motif Proteins | 1 | 2020 | 55 | 0.050 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2021 | 69 | 0.050 |
Why?
|
| DNA Repair Enzymes | 1 | 2022 | 237 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2000 | 329 | 0.050 |
Why?
|
| Checkpoint Kinase 1 | 2 | 2014 | 174 | 0.050 |
Why?
|
| Oxysterols | 1 | 2020 | 3 | 0.050 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 15 | 0.050 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2020 | 32 | 0.050 |
Why?
|
| Fluorouracil | 2 | 2015 | 1944 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2002 | 869 | 0.050 |
Why?
|
| Lomustine | 1 | 2020 | 39 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 1054 | 0.050 |
Why?
|
| Retinal Neoplasms | 1 | 2022 | 144 | 0.050 |
Why?
|
| Retinoblastoma | 1 | 2022 | 200 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 2265 | 0.050 |
Why?
|
| Poly ADP Ribosylation | 1 | 2019 | 9 | 0.050 |
Why?
|
| Thiophenes | 1 | 2021 | 148 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 1058 | 0.050 |
Why?
|
| Tumor Stem Cell Assay | 2 | 1998 | 231 | 0.050 |
Why?
|
| Muscle Strength | 1 | 2020 | 104 | 0.050 |
Why?
|
| para-Aminobenzoates | 1 | 2019 | 10 | 0.050 |
Why?
|
| Carcinoma in Situ | 1 | 2003 | 487 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2006 | 1171 | 0.050 |
Why?
|
| Isomerism | 1 | 2019 | 63 | 0.050 |
Why?
|
| GATA3 Transcription Factor | 1 | 2020 | 146 | 0.040 |
Why?
|
| Mitoxantrone | 1 | 2020 | 216 | 0.040 |
Why?
|
| Benzoxazoles | 1 | 2020 | 41 | 0.040 |
Why?
|
| Cigarette Smoking | 1 | 2020 | 88 | 0.040 |
Why?
|
| Tretinoin | 1 | 2002 | 623 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2001 | 311 | 0.040 |
Why?
|
| Drug Interactions | 2 | 2004 | 553 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2022 | 12873 | 0.040 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2019 | 38 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 694 | 0.040 |
Why?
|
| Sequence Deletion | 3 | 1997 | 875 | 0.040 |
Why?
|
| Caspase 8 | 2 | 2011 | 145 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2021 | 351 | 0.040 |
Why?
|
| Protein Conformation | 3 | 2016 | 1258 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2019 | 143 | 0.040 |
Why?
|
| Allografts | 1 | 2021 | 650 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 1998 | 74 | 0.040 |
Why?
|
| Cholesterol | 1 | 2002 | 658 | 0.040 |
Why?
|
| Caspase 9 | 2 | 2012 | 189 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1998 | 93 | 0.040 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2003 | 674 | 0.040 |
Why?
|
| I-kappa B Proteins | 2 | 2011 | 170 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 342 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2019 | 107 | 0.040 |
Why?
|
| Chemotaxis | 1 | 2019 | 138 | 0.040 |
Why?
|
| Purines | 2 | 2013 | 273 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2022 | 2291 | 0.040 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 1998 | 35 | 0.040 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2018 | 31 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 211 | 0.040 |
Why?
|
| Osteopontin | 1 | 2019 | 148 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 198 | 0.040 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2018 | 76 | 0.040 |
Why?
|
| CpG Islands | 1 | 2020 | 633 | 0.040 |
Why?
|
| Collagen Type IV | 1 | 2019 | 108 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 234 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 2594 | 0.040 |
Why?
|
| Neoplasm Grading | 2 | 2014 | 1742 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 206 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2018 | 299 | 0.040 |
Why?
|
| Mastectomy, Segmental | 1 | 2004 | 1026 | 0.040 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2007 | 1105 | 0.040 |
Why?
|
| Bevacizumab | 1 | 2022 | 938 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 157 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 904 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2014 | 10001 | 0.040 |
Why?
|
| Crystallography, X-Ray | 2 | 2010 | 627 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 368 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2017 | 97 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1997 | 118 | 0.040 |
Why?
|
| China | 1 | 2019 | 606 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 741 | 0.040 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2017 | 22 | 0.040 |
Why?
|
| Enzyme Assays | 1 | 2017 | 22 | 0.040 |
Why?
|
| Organoids | 1 | 2019 | 287 | 0.040 |
Why?
|
| Aminopyridines | 1 | 2019 | 212 | 0.040 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2017 | 33 | 0.040 |
Why?
|
| Prednisone | 1 | 2020 | 984 | 0.040 |
Why?
|
| Chemokines | 1 | 2018 | 314 | 0.040 |
Why?
|
| Mastectomy | 1 | 2004 | 1534 | 0.040 |
Why?
|
| Neuregulin-1 | 2 | 2010 | 83 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 1997 | 197 | 0.040 |
Why?
|
| Defective Viruses | 1 | 1996 | 28 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2018 | 626 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 430 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2017 | 300 | 0.040 |
Why?
|
| NADP | 1 | 2017 | 96 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 1320 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 1242 | 0.040 |
Why?
|
| Mitochondria | 3 | 2009 | 1282 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 96 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2009 | 521 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2016 | 23 | 0.040 |
Why?
|
| Biopsy, Needle | 3 | 2005 | 1363 | 0.040 |
Why?
|
| NADPH Oxidases | 1 | 2017 | 146 | 0.040 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2017 | 106 | 0.040 |
Why?
|
| DNA, Neoplasm | 2 | 2000 | 1910 | 0.040 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2016 | 21 | 0.040 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2016 | 21 | 0.040 |
Why?
|
| Angiotensin I | 1 | 2016 | 18 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2016 | 65 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2015 | 52 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 132 | 0.030 |
Why?
|
| Monocytes | 2 | 2017 | 788 | 0.030 |
Why?
|
| Candida albicans | 1 | 2017 | 175 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2017 | 243 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 2016 | 144 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2017 | 396 | 0.030 |
Why?
|
| Disease Management | 1 | 2021 | 1052 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 1999 | 649 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2017 | 253 | 0.030 |
Why?
|
| Phosphatidylinositols | 1 | 2015 | 60 | 0.030 |
Why?
|
| Decorin | 1 | 2015 | 13 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 131 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 78 | 0.030 |
Why?
|
| Porphyrins | 1 | 2015 | 37 | 0.030 |
Why?
|
| Nanog Homeobox Protein | 1 | 2015 | 65 | 0.030 |
Why?
|
| Proline | 1 | 2016 | 130 | 0.030 |
Why?
|
| Safety | 1 | 1997 | 465 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 314 | 0.030 |
Why?
|
| Melanocytes | 1 | 2016 | 219 | 0.030 |
Why?
|
| Triazoles | 1 | 2019 | 617 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2022 | 2803 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 323 | 0.030 |
Why?
|
| Pyrroles | 1 | 2019 | 576 | 0.030 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2019 | 690 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2015 | 107 | 0.030 |
Why?
|
| Spleen | 1 | 1997 | 676 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 278 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 610 | 0.030 |
Why?
|
| Trachea | 1 | 1996 | 259 | 0.030 |
Why?
|
| Receptor, Notch2 | 1 | 2014 | 25 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 2014 | 46 | 0.030 |
Why?
|
| Transcription Factor HES-1 | 1 | 2014 | 49 | 0.030 |
Why?
|
| Gene Amplification | 2 | 2009 | 731 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 88 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2016 | 382 | 0.030 |
Why?
|
| Printing | 1 | 2014 | 7 | 0.030 |
Why?
|
| Micromanipulation | 1 | 2014 | 10 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2020 | 6100 | 0.030 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2014 | 85 | 0.030 |
Why?
|
| Biological Transport | 1 | 2016 | 597 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 208 | 0.030 |
Why?
|
| Cdh1 Proteins | 1 | 2014 | 18 | 0.030 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2014 | 54 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2018 | 1144 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2005 | 208 | 0.030 |
Why?
|
| Dual Specificity Phosphatase 3 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Jagged-1 Protein | 1 | 2014 | 101 | 0.030 |
Why?
|
| HMGA2 Protein | 1 | 2013 | 19 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 463 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2014 | 110 | 0.030 |
Why?
|
| Adenoma | 1 | 2019 | 716 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 2483 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 261 | 0.030 |
Why?
|
| Octamer Transcription Factor-2 | 1 | 2013 | 7 | 0.030 |
Why?
|
| Pre-B-Cell Leukemia Transcription Factor 1 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Valosin Containing Protein | 1 | 2013 | 14 | 0.030 |
Why?
|
| Young Adult | 3 | 2018 | 21445 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2010 | 624 | 0.030 |
Why?
|
| Etoposide | 1 | 1996 | 870 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 1081 | 0.030 |
Why?
|
| Cytarabine | 1 | 2020 | 1973 | 0.030 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2014 | 113 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1440 | 0.030 |
Why?
|
| S Phase Cell Cycle Checkpoints | 1 | 2013 | 6 | 0.030 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2013 | 32 | 0.030 |
Why?
|
| TCF Transcription Factors | 1 | 2013 | 35 | 0.030 |
Why?
|
| Pancreas | 1 | 2017 | 718 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2013 | 123 | 0.030 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 74 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2013 | 83 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2013 | 45 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2014 | 208 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 314 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2013 | 250 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 644 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2013 | 62 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2013 | 223 | 0.030 |
Why?
|
| CCN Intercellular Signaling Proteins | 1 | 2012 | 7 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8865 | 0.030 |
Why?
|
| Xanthenes | 1 | 2012 | 8 | 0.030 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 161 | 0.030 |
Why?
|
| Luciferases, Firefly | 1 | 2012 | 39 | 0.030 |
Why?
|
| Osteolysis | 1 | 2013 | 80 | 0.030 |
Why?
|
| Cyclohexanes | 1 | 2012 | 38 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 2012 | 57 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 2013 | 111 | 0.030 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2013 | 107 | 0.030 |
Why?
|
| Sequestosome-1 Protein | 1 | 2012 | 39 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2013 | 267 | 0.030 |
Why?
|
| Xenopus | 1 | 2012 | 219 | 0.030 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2011 | 29 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 253 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 401 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 85 | 0.030 |
Why?
|
| B-Cell CLL-Lymphoma 10 Protein | 1 | 2011 | 30 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 1323 | 0.020 |
Why?
|
| Smoking | 1 | 2020 | 2440 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2020 | 1823 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 2007 | 844 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2011 | 136 | 0.020 |
Why?
|
| Genotype | 2 | 2010 | 4109 | 0.020 |
Why?
|
| Relaxin | 1 | 2010 | 21 | 0.020 |
Why?
|
| Thrombospondin 1 | 1 | 2011 | 55 | 0.020 |
Why?
|
| Drug Antagonism | 1 | 2010 | 32 | 0.020 |
Why?
|
| Plant Bark | 1 | 2010 | 5 | 0.020 |
Why?
|
| KB Cells | 1 | 2010 | 18 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 598 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2010 | 57 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2012 | 246 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 254 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2011 | 334 | 0.020 |
Why?
|
| Gene Order | 1 | 2010 | 111 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 71 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2010 | 77 | 0.020 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 2010 | 19 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2010 | 164 | 0.020 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2010 | 26 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2013 | 310 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 622 | 0.020 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2010 | 42 | 0.020 |
Why?
|
| Injections, Intralesional | 2 | 2002 | 164 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2014 | 3719 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 2010 | 184 | 0.020 |
Why?
|
| CD146 Antigen | 1 | 2009 | 57 | 0.020 |
Why?
|
| Androgens | 1 | 2013 | 511 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2009 | 115 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2010 | 302 | 0.020 |
Why?
|
| Cyclophilins | 1 | 2009 | 32 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2014 | 1450 | 0.020 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2009 | 103 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2010 | 360 | 0.020 |
Why?
|
| Ku Autoantigen | 1 | 2009 | 79 | 0.020 |
Why?
|
| Pyrazines | 1 | 2012 | 495 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 651 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2009 | 119 | 0.020 |
Why?
|
| K562 Cells | 1 | 2009 | 338 | 0.020 |
Why?
|
| Phosphothreonine | 1 | 2008 | 20 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2008 | 89 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2008 | 107 | 0.020 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2007 | 27 | 0.020 |
Why?
|
| Benzamidines | 1 | 2007 | 12 | 0.020 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2007 | 25 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 1859 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 77 | 0.020 |
Why?
|
| Glutathione | 1 | 2009 | 368 | 0.020 |
Why?
|
| Estrogens | 1 | 2010 | 751 | 0.020 |
Why?
|
| Contactins | 1 | 2006 | 5 | 0.020 |
Why?
|
| Contactin 1 | 1 | 2006 | 5 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2007 | 298 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2007 | 241 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2005 | 118 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2006 | 101 | 0.020 |
Why?
|
| Metaplasia | 1 | 2007 | 383 | 0.020 |
Why?
|
| Lithium Chloride | 1 | 2005 | 28 | 0.020 |
Why?
|
| Aminophenols | 1 | 2005 | 12 | 0.020 |
Why?
|
| Maleimides | 1 | 2005 | 22 | 0.020 |
Why?
|
| Uterus | 1 | 2010 | 678 | 0.020 |
Why?
|
| Antimanic Agents | 1 | 2005 | 39 | 0.020 |
Why?
|
| Adolescent | 2 | 2016 | 31252 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 891 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 2422 | 0.020 |
Why?
|
| Contraceptive Agents, Female | 1 | 2004 | 38 | 0.020 |
Why?
|
| Child | 2 | 2016 | 29154 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2004 | 105 | 0.020 |
Why?
|
| Culture Techniques | 1 | 2003 | 132 | 0.010 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2004 | 129 | 0.010 |
Why?
|
| Research Design | 1 | 2011 | 1544 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 170 | 0.010 |
Why?
|
| Dimerization | 1 | 2004 | 304 | 0.010 |
Why?
|
| Proteasome Inhibitors | 1 | 2005 | 231 | 0.010 |
Why?
|
| Suction | 1 | 2003 | 104 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 212 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2004 | 316 | 0.010 |
Why?
|
| Virus Replication | 1 | 2006 | 709 | 0.010 |
Why?
|
| Remission Induction | 1 | 2009 | 3569 | 0.010 |
Why?
|
| Tumor Protein p73 | 1 | 2002 | 105 | 0.010 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2002 | 95 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2002 | 132 | 0.010 |
Why?
|
| Reference Standards | 1 | 2003 | 339 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 7702 | 0.010 |
Why?
|
| Organelles | 1 | 2002 | 40 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 3441 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 3890 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2009 | 1824 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2012 | 1833 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2002 | 365 | 0.010 |
Why?
|
| Drug Carriers | 1 | 2002 | 327 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 1890 | 0.010 |
Why?
|
| Doxycycline | 1 | 2001 | 178 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1998 | 70 | 0.010 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 1998 | 55 | 0.010 |
Why?
|
| Adenoviridae Infections | 1 | 1998 | 125 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 1997 | 61 | 0.010 |
Why?
|
| Temperature | 1 | 1998 | 506 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1997 | 132 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 4549 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1997 | 222 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 153 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1996 | 184 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 1994 | 67 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2007 | 6869 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 6550 | 0.010 |
Why?
|